Dr. Fosker is a clinical oncologist and a consultant at Brigham and Women's Hospital, Boston. As of April 1, 2025 he is the Centre's CEO & medical director.

As a breast specialist radiologist, Dr Risk is a medical doctor specialising in diagnosing breast disease using mammography and ultrasound. Hailing from Canada, Risk has spent the past 19 years playing an integral role as part of his group providing the vast majority of breast imaging and biopsies for the greater Calgary area and beyond.

Dr. Patrick Murray has moved from the UK, where he worked as a Consultant Clinical Oncologist at Leeds Teaching Hospitals NHS Trust. Patrick brings a focus on high precision radiation techniques such as SBRT and SRS with a specialisation in head and neck cancer.

The Bermuda Cancer Genetics and Risk Assessment programme is led by Dr Kevin S. Hughes, MD, FACS, Director of Cancer Genetics at the Medical University of South Carolina and Professor Emeritus at Harvard Medical School.

With over 30 years of experience, he ensures Bermuda’s programme reflects international standards while focusing on thoughtful, individualised risk assessment and prevention.

Michele Hypolite is a Cancer Navigator at Bermuda Cancer and Health Centre with extensive oncology nursing experience in Australia and Bermuda. She holds a Bachelor of Nursing, with postgraduate certifications in Oncology and Health Services Management.

She supports patients and their families throughout the cancer journey, helping them navigate care, access services, and feel informed and supported every step of the way.

Sarah Dyball-Bladon is the Chief Nurse for Oncology at Bermuda Cancer and Health Centre, with over 12 years of specialist experience in the UK and Bermuda. She is focused on delivering compassionate, patient-centred care and developing services that improve patient experience and continuity across the cancer pathway.